Search Results
Found 1 results
510(k) Data Aggregation
(247 days)
Hemi arthroplasty implant for first metatarsophalangeal joint for use in the treatment of patients with degenerative and post-traumatic arthritis in the first metatarsal joint in the presence of good bone stock along with the following clinical conditions; hallux valgus or hallux limitus, hallux rigidus, and an unstable or painful metatarsal/phalangeal (MTP) joint. The device is a single use implant intended to be used with bone cement.
The CAP™ Great Toe Resurfacinq Hemi-arthroplasty implant is a cobalt chrome alloy, 2-piece implant to supplement first metatarsal phalangeal joint arthroplasty. The implant is designed to provide a smooth surface for the first metatarsophalangeal joint as a the treatment of patients with degenerative and post-traumatic arthritis in the first metatarsal joint in the presence of good bone stock along with the following clinical conditions; hallux valqus or hallux limitus, hallux rigidus, and an unstable or painful metatarsal/phalangeal (MTP) joint. The device is a single use implant intended to be used with bone cement.
The CAP™ Great Toe Resurfacing Hemi-arthroplasty implant consists of two components, a taper post component and an articular component, that mate together via a taper interlock to provide stable and immobile fixation of the implant and stress bearing contact at the bone/prosthetic interface.
The first implant component is a Taper Post manufactured of a Ti-6AI-4V ELI alloy per ASTM F136. The Taper Post has a tapering distal tip, a full-length cannulation, and a proximal female taper bore.
The second implant is an articular component manufactured of a Cobalt-Chromium-Molybdenum alloy per ASTM F799 and ASTM F1537. The articular component has a bone contact surface that is coated with a CP Titanium coating and a polished articular bearing surface.
The provided text describes the safety and effectiveness of the CAP™ Great Toe Resurfacing Hemi-arthroplasty implant. It is a medical device, and the information presented here pertains to its mechanical performance and substantial equivalence to previously marketed devices, not to the performance of a software or AI/ML-based device. Therefore, many of the requested categories for AI/ML device studies are not applicable.
Here's an analysis based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria | Reported Device Performance |
---|---|
Mechanical Test Protocol (per CDRH Guidance for Testing Non-Articulating, Mechanically Locked, Modular Implant Components and ASTM F 1814): | |
- Axial Assembly and Disassembly | Meets established acceptance criteria in accordance with identified industry standards. |
- Rigidity Characterization | Meets established acceptance criteria in accordance with identified industry standards. |
- Cyclic Fatigue Failure, Disassembly | Meets established acceptance criteria in accordance with identified industry standards. |
- Fretting, Fretting/Corrosion (ASTM F897) | Meets established acceptance criteria in accordance with identified industry standards. |
- Resistance to Torque of Head Fixation (ISO 7206-9) | Meets established acceptance criteria in accordance with identified industry standards. |
Vacuum Plasma Spray Applied Surface Coating (per CDRH Guidance for Testing Orthopedic Implants with Modified Metallic Surfaces Apposing Bone or Cement): | Documentation exists in the Bio-Coat Master Device File MAF-1085, indicating the surface coating meets established guidelines. |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
- The document describes non-clinical mechanical testing of the device components. It does not mention a "test set" in the context of patient data or clinical data.
- The sample sizes for the mechanical tests are not explicitly stated in the provided text.
- Data provenance is not applicable as this relates to mechanical testing, not patient data.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
- This is not applicable as the study involves mechanical testing of an implant, not a diagnostic or prognostic device requiring expert interpretation of data. The "ground truth" here is the physical and mechanical properties of the device as measured against established engineering standards.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
- This is not applicable since the testing is mechanical and does not involve adjudication of expert opinions.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- This is not applicable as the device is an orthopedic implant, not an AI-assisted diagnostic tool.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
- This is not applicable as the device is a physical implant, not an algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
- The "ground truth" for this device, in the context of the described testing, is adherence to established industry standards and guidelines for mechanical properties and material performance (e.g., ASTM F1814, ASTM F897, ISO 7206-9, and relevant CDRH Guidance Documents for implants).
8. The sample size for the training set
- This is not applicable; there is no "training set" as this is a physical medical device, not an AI/ML algorithm.
9. How the ground truth for the training set was established
- This is not applicable.
Ask a specific question about this device
Page 1 of 1